Learn how to use the brand new 7-course program to get new business partners started out right!

Shaklee Chairman and CEO Roger Barnett interview Dr Anne Wyllie, an epidemiologist from Yale, who developed Saliva Direct, the first saliva-based rapid response test which the NBA is using to keep their “bubble” safe and which promises to provide rapid, cost-effective solutions as communities look to expand testing in the coming year.

Expanding Your Network

Maximize member referrals to build relationships and set the stage for expanding your business

Shaklee Chairman and CEO Roger Barnett interviews Michelle A Williams, Dean of the Harvard School of Public Health about what people can do to keep their communities safe during the current pandemic, and how racism plays a role in public health.

Shaklee Chairman and CEO Roger Barnett interview Dr Anne Wyllie, an epidemiologist from Yale, who developed Saliva Direct, the first saliva-based rapid response test which the NBA is using to keep their “bubble” safe and which promises to provide rapid, cost-effective solutions as communities look to expand testing in the coming year.

Hear from Shaklee experts about the latest innovations, with a focus on Meology™ and Immunity.

Hear from Shaklee experts about the latest innovations, with a focus on Meology™ and Immunity.

Shaklee Chairman and CEO Roger Barnett interviews Dr Kari Nadeau and Sloan Barnett, co-authors of “The End of Allergies,” which explains the proven methods Dr Nadeau uses to desensitize people to some of the most common and troubling allergens.

Shaklee Chairman and CEO Roger Barnett interviews Dr Kari Nadeau and Sloan Barnett, co-authors of “The End of Allergies,” which explains the proven methods Dr Nadeau uses to desensitize people to some of the most common and troubling allergens.